Universitätsklinikum Ulm

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023 (2023) Park-Simon TW, Müller V, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, et al. Journal article, Review article Positionspapier „Universitäre Karrierewege“ (2023) Staudacher JJ, Backes M, Bettinger D, Blüthner E, Dietz-Fricke C, Dugic A, Fusco S, et al. Journal article Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation (2023) Heinz AT, Calkoen FG, Derbich A, Miltner L, Seitz C, Doering M, Braun C, et al. Journal article Exome Survey and Candidate Gene Re-Sequencing Identifies Novel Exstrophy Candidate Genes and Implicates LZTR1 in Disease Formation (2023) Köllges R, Stegmann J, Schneider S, Waffenschmidt L, Fazaal J, Breuer K, Hilger AC, et al. Journal article Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG (2023) Zaremba A, Mohr P, Gutzmer R, Meier F, Pföhler C, Weichenthal M, Terheyden P, et al. Journal article Fetal Assessment in Pregnancy (Indication and Methodology for Fetal Monitoring in a Low-risk Population)Guideline of the DGGG, DEGUM, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/089, February 2023) (2023) Schiermeier S, Von Kaisenberg CS, Kehl S, Reister F, Mosimann B, Reif P, Harlfinger W, et al. Journal article Patient’s Desire and Real Availability Concerning Supportive Measures Accompanying Radical Prostatectomy: Differences between Certified Prostate Cancer Centers and Non-Certified Centers Based on Patient-Reported Outcomes within the Cross-Sectional Study Improve (2023) Wolff I, Burchardt M, Peter J, Thomas C, Sikic D, Fiebig C, Promnitz S, et al. Journal article ALS is imprinted in the chromatin accessibility of blood cells (2023) Kühlwein JK, Ruf WP, Kandler K, Witzel S, Lang C, Mulaw MA, Ekici AB, et al. Journal article Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041) (2023) Fasching P, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, et al. Journal article Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations (2023) Untch M, Banys-Paluchowski M, Brucker SY, Budach W, Denkert C, Ditsch N, Fasching P, et al. Journal article